Trials / Recruiting
RecruitingNCT07368972
Study of DISC-0974-201 in Participants With IBD and Anemia
RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- Sponsor
- Disc Medicine, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DISC-0974 | DISC-0974 is administered subcutaneously. |
| DRUG | Placebo | Placebo is administered subcutaneously |
Timeline
- Start date
- 2026-02-20
- Primary completion
- 2026-10-01
- Completion
- 2027-03-01
- First posted
- 2026-01-27
- Last updated
- 2026-04-17
Locations
8 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07368972. Inclusion in this directory is not an endorsement.